FDA Approves Updated Starting Dose Guidelines for Inhaled Insulin Powder (Afrezza)
The US Food and Drug Administration (FDA) has approved an updated label for insulin human (Afrezza) inhalation powder, which provides guidance for starting dosages when switching from multiple daily injections…